These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29951208)

  • 1. Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities.
    Thambavita D; Galappatthy P; Jayakody RL
    J Pharm Policy Pract; 2018; 11():14. PubMed ID: 29951208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Analysis of Generic Drug Assessment and Regulatory Approval in the USA, Europe and India.
    Patel BD; Suthar SP; Mansuri AM; Joshi VD
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2024 Oct; 40():e20240029. PubMed ID: 39384543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.
    Davit BM; Kanfer I; Tsang YC; Cardot JM
    AAPS J; 2016 May; 18(3):612-8. PubMed ID: 26943914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro Assays.
    Miranda-Pérez de Alejo C; Aceituno Álvarez A; Mendes Lima Santos G; Fernández Cervera M; Jung-Cook H; Cabrera-Pérez MÁ
    Ther Innov Regul Sci; 2021 Jan; 55(1):65-81. PubMed ID: 32602028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO/INRUD Core drug use indicators and commonly prescribed medicines: a National Survey from Sri Lanka.
    Galappatthy P; Ranasinghe P; Liyanage CK; Wijayabandara MS; Mythily S; Jayakody RL
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):67. PubMed ID: 34711271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of the Drug Registration Requirements for Export to Tanzania, Nepal, and Cambodia.
    Shelke TV; Khante S; Sarda MB; Mahadik KR; Gaikwad VL
    Ther Innov Regul Sci; 2020 Jan; 54(1):171-176. PubMed ID: 32008246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory requirements and labeling of commercially available prescription (oral) medicines in Sri Lanka: there is room for improvement.
    Jayasinghe M; Srilal TLI; Prasadi DGP; Madushika WSS; Silva SMDU; Subasinghe S
    J Pharm Policy Pract; 2022 Mar; 15(1):13. PubMed ID: 35232496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences.
    Davit B; Braddy AC; Conner DP; Yu LX
    AAPS J; 2013 Oct; 15(4):974-90. PubMed ID: 23821352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution Profiles of Generic Products in Dissolution Media Defined by Japanese Guidelines for Bioequivalence Studies.
    Kajiwara E; Kamizato H; Shikano M
    Ther Innov Regul Sci; 2021 Sep; 55(5):1096-1100. PubMed ID: 34097289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries.
    Miranda C; Aceituno A; Fernández M; Mendes G; Rodríguez Y; Llauró V; Cabrera-Pérez MÁ
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
    Sithole T; Mahlangu G; Walker S; Salek S
    Front Med (Lausanne); 2022; 9():898725. PubMed ID: 35547215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Discriminatory Power of the BCS-Based Biowaiver: A Retrospective With Focus on Essential Medicines.
    Hofsäss MA; Dressman JB
    J Pharm Sci; 2019 Sep; 108(9):2824-2837. PubMed ID: 31059698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the review models and approval timelines of authorities participating in the East African Medicine Regulatory Harmonisation initiative: alignment and strategies for moving forward.
    Ngum N; Ndomondo-Sigonda M; Habonimana R; Siyoi F; Irasabwa C; Ojukwu J; Apolinary F; Okello A; Ahmada S; Walker S; Salek S
    Front Med (Lausanne); 2024; 11():1438041. PubMed ID: 39355848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence Common Deficiencies in Generic Products Submitted for Registration to the South African Health Products Regulatory Authority (SAHPRA).
    Moeti L; Litedu M; Joubert J
    Ther Innov Regul Sci; 2022 Sep; 56(5):822-838. PubMed ID: 35896784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
    Dabare PR; Wanigatunge CA; Beneragama BH
    BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMCP Format dossier requests: manufacturer response and formulary implications for one large health plan.
    Spooner JJ; Gandhi PK; Connelly SB
    J Manag Care Pharm; 2007; 13(1):37-43. PubMed ID: 17269835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey of the Regulatory Requirements for BCS-Based Biowaivers for Solid Oral Dosage Forms by Participating Regulators and Organisations of the International Generic Drug Regulators Programme.
    Van Oudtshoorn JE; García-Arieta A; Santos GML; Crane C; Rodrigues C; Simon C; Kim JM; Park SA; Okada Y; Kuribayashi R; Pfäffli C; Nolting A; Lojero IOC; Martínez ZR; Hung WY; Braddy AC; Leal NA; Triana DG; Clarke M; Bachmann P
    J Pharm Pharm Sci; 2018; 21(1):27-37. PubMed ID: 29382433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research Applications.
    Argotti U; Leyens L; Lisbona C; López P; Alonso-Orgaz S; Nevado A; Cozzi V
    Ther Innov Regul Sci; 2023 Nov; 57(6):1287-1297. PubMed ID: 37682461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.